# AppTech Payments Corp.: financial statements, quarterly

APCX · OTC · CIK 1070050 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/apcx.md) · [Financials](/companies/apcx/financials.md) · [Filings](/companies/apcx/filings.md) · [Insiders](/companies/apcx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/apcx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [140](/filings/0001683168-24-008207.md) | [141 d](/filings/0001683168-25-002130.md) | [105](/filings/0001683168-25-003561.md) | [76.0](/filings/0001683168-25-006148.md) | [43.0](/filings/0001683168-25-008326.md) | [52.0 d](/filings/0001683168-26-002518.md) | [217](/filings/0001683168-26-004002.md) | [291](/filings/0001683168-26-006441.md) | [227](/filings/0001683168-25-008326.md) | [660 d](/filings/0001683168-26-002518.md) | [1,457](/filings/0001683168-26-004002.md) | [1,657](/filings/0001683168-26-006441.md) |
| Cost of revenue | $k | [44.0](/filings/0001683168-24-008207.md) | [28.0 d](/filings/0001683168-25-002130.md) | [11.0](/filings/0001683168-25-003561.md) | [14.0](/filings/0001683168-25-006148.md) | [24.0](/filings/0001683168-25-008326.md) | [3.0 d](/filings/0001683168-26-002518.md) | [128](/filings/0001683168-26-004002.md) | [107](/filings/0001683168-26-006441.md) | [100](/filings/0001683168-25-008326.md) | [289 d](/filings/0001683168-26-002518.md) | [646](/filings/0001683168-26-004002.md) | [772](/filings/0001683168-26-006441.md) |
| Gross profit | $k | [96.0](/filings/0001683168-24-008207.md) | [113 d](/filings/0001683168-25-002130.md) | [94.0](/filings/0001683168-25-003561.md) | [62.0](/filings/0001683168-25-006148.md) | [19.0](/filings/0001683168-25-008326.md) | [49.0 d](/filings/0001683168-26-002518.md) | [89.0](/filings/0001683168-26-004002.md) | [184](/filings/0001683168-26-006441.md) | [127](/filings/0001683168-25-008326.md) | [371 d](/filings/0001683168-26-002518.md) | [811](/filings/0001683168-26-004002.md) | [885](/filings/0001683168-26-006441.md) |
| Research and development | $k | [751](/filings/0001683168-24-008207.md) | [724 d](/filings/0001683168-25-002130.md) | [644](/filings/0001683168-25-003561.md) | [633](/filings/0001683168-25-006148.md) | [2.0](/filings/0001683168-25-008326.md) | [699 d](/filings/0001683168-26-002518.md) | [780](/filings/0001683168-26-004002.md) | [910](/filings/0001683168-26-006441.md) | [325](/filings/0001683168-25-008326.md) | [332 d](/filings/0001683168-26-002518.md) | [375](/filings/0001683168-26-004002.md) | [332](/filings/0001683168-26-006441.md) |
| Selling, general and administrative | $k | [2,227](/filings/0001683168-24-008207.md) | [2,759 d](/filings/0001683168-25-002130.md) | [2,481](/filings/0001683168-25-003561.md) | [2,320](/filings/0001683168-25-006148.md) | [1,867](/filings/0001683168-25-008326.md) | [1,125 d](/filings/0001683168-26-002518.md) | [1,965](/filings/0001683168-26-004002.md) | [1,155](/filings/0001683168-26-006441.md) | [1,373](/filings/0001683168-25-008326.md) | [1,510 d](/filings/0001683168-26-002518.md) | [3,284](/filings/0001683168-26-004002.md) | [1,441](/filings/0001683168-26-006441.md) |
| Operating income | $k | [(2,882)](/filings/0001683168-24-008207.md) | [(3,370) d](/filings/0001683168-25-002130.md) | [(3,031)](/filings/0001683168-25-003561.md) | [(2,891)](/filings/0001683168-25-006148.md) | [(1,850)](/filings/0001683168-25-008326.md) | [(1,775) d](/filings/0001683168-26-002518.md) | [(2,656)](/filings/0001683168-26-004002.md) | [(1,881)](/filings/0001683168-26-006441.md) | [(1,571)](/filings/0001683168-25-008326.md) | [(1,471) d](/filings/0001683168-26-002518.md) | [(2,848)](/filings/0001683168-26-004002.md) | [(888)](/filings/0001683168-26-006441.md) |
| Interest expense | $k | [4.0](/filings/0001683168-24-008207.md) | [4.0 d](/filings/0001683168-24-002017.md) | [3.0](/filings/0001683168-24-003412.md) | [32.0](/filings/0001683168-24-005596.md) | [18.0](/filings/0001683168-24-008207.md) | [(27.0) d](/filings/0001683168-25-002130.md) | [33.0](/filings/0001683168-26-004002.md) | [(26.0)](/filings/0001683168-26-006441.md) | not reported | not reported | [196](/filings/0001683168-26-004002.md) | [209](/filings/0001683168-26-006441.md) |
| Income tax | $k | [0.0](/filings/0001683168-24-008207.md) | [0.0 d](/filings/0001683168-25-002130.md) | [0.0](/filings/0001683168-25-003561.md) | [0.0](/filings/0001683168-25-006148.md) | [0.0](/filings/0001683168-25-008326.md) | [0.0 d](/filings/0001683168-26-002518.md) | [0.0](/filings/0001683168-26-004002.md) | [0.0](/filings/0001683168-26-006441.md) | [0.0](/filings/0001683168-25-008326.md) | [0.0 d](/filings/0001683168-26-002518.md) | [0.0](/filings/0001683168-26-004002.md) | [0.0](/filings/0001683168-26-006441.md) |
| Net income | $k | [(2,891)](/filings/0001683168-24-008207.md) | [(3,387) d](/filings/0001683168-25-002130.md) | [(3,037)](/filings/0001683168-25-008326.md) | [(2,922)](/filings/0001683168-25-008326.md) | [(2,025)](/filings/0001683168-25-008326.md) | [(949) d](/filings/0001683168-26-002518.md) | [(2,641)](/filings/0001683168-26-006441.md) | [(1,860)](/filings/0001683168-26-006441.md) | [(1,731)](/filings/0001683168-25-008326.md) | [(1,688) d](/filings/0001683168-26-002518.md) | [(3,308)](/filings/0001683168-26-006441.md) | [(1,012)](/filings/0001683168-26-006441.md) |
| Diluted EPS | $ per share | [(0.15)](/filings/0001683168-24-008207.md) | not reported | [(0.13)](/filings/0001683168-25-003561.md) | [(0.12)](/filings/0001683168-25-006148.md) | [(0.08)](/filings/0001683168-25-008326.md) | not reported | [(0.08)](/filings/0001683168-26-004002.md) | [(0.06)](/filings/0001683168-26-006441.md) | [(0.05)](/filings/0001683168-25-008326.md) | not reported | [(0.08)](/filings/0001683168-26-004002.md) | [(0.02)](/filings/0001683168-26-006441.md) |
| Basic EPS | $ per share | [(0.15)](/filings/0001683168-24-008207.md) | not reported | [(0.13)](/filings/0001683168-25-003561.md) | [(0.12)](/filings/0001683168-25-006148.md) | [(0.08)](/filings/0001683168-25-008326.md) | not reported | [(0.08)](/filings/0001683168-26-004002.md) | [(0.06)](/filings/0001683168-26-006441.md) | [(0.05)](/filings/0001683168-25-008326.md) | not reported | [(0.08)](/filings/0001683168-26-004002.md) | [(0.02)](/filings/0001683168-26-006441.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $k | not reported | not reported | [1,553](/filings/0001683168-24-003412.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $k | [828](/filings/0001683168-23-008030.md) | [1,516](/filings/0001683168-25-002130.md) | [1,760](/filings/0001683168-24-003412.md) | [328](/filings/0001683168-24-005596.md) | [312](/filings/0001683168-24-008207.md) | [2,420](/filings/0001683168-26-002518.md) | [739](/filings/0001683168-25-003561.md) | [397](/filings/0001683168-25-006148.md) | [565](/filings/0001683168-25-008326.md) | [915](/filings/0001683168-26-006441.md) | [1,090](/filings/0001683168-26-004002.md) | [980](/filings/0001683168-26-006441.md) |
| Total assets | $k | [2,443](/filings/0001683168-23-008030.md) | [8,353](/filings/0001683168-25-002130.md) | [8,250](/filings/0001683168-24-003412.md) | [6,464](/filings/0001683168-24-005596.md) | [6,614](/filings/0001683168-24-008207.md) | [8,986](/filings/0001683168-26-002518.md) | [6,911](/filings/0001683168-25-003561.md) | [6,486](/filings/0001683168-25-006148.md) | [6,246](/filings/0001683168-25-008326.md) | [9,393](/filings/0001683168-26-006441.md) | [9,136](/filings/0001683168-26-004002.md) | [8,943](/filings/0001683168-26-006441.md) |
| Current liabilities | $k | [1,528](/filings/0001683168-23-008030.md) | [4,080](/filings/0001683168-25-002130.md) | [4,105](/filings/0001683168-24-003412.md) | [4,661](/filings/0001683168-24-005596.md) | [5,153](/filings/0001683168-24-008207.md) | [3,440](/filings/0001683168-26-002518.md) | [3,188](/filings/0001683168-25-003561.md) | [3,891](/filings/0001683168-25-006148.md) | [4,770](/filings/0001683168-25-008326.md) | [6,441](/filings/0001683168-26-006441.md) | [6,682](/filings/0001683168-26-004002.md) | [6,807](/filings/0001683168-26-006441.md) |
| Total liabilities | $k | [1,627](/filings/0001683168-23-008030.md) | [4,159](/filings/0001683168-25-002130.md) | [4,168](/filings/0001683168-24-003412.md) | [4,724](/filings/0001683168-24-005596.md) | [5,215](/filings/0001683168-24-008207.md) | [3,519](/filings/0001683168-26-002518.md) | [3,249](/filings/0001683168-25-003561.md) | [3,951](/filings/0001683168-25-006148.md) | [4,830](/filings/0001683168-25-008326.md) | [7,500](/filings/0001683168-26-006441.md) | [8,839](/filings/0001683168-26-004002.md) | [9,374](/filings/0001683168-26-006441.md) |
| Long-term debt | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $k | [816](/filings/0001683168-24-008207.md) | [4,194](/filings/0001683168-26-002518.md) | [4,082](/filings/0001683168-25-008326.md) | [1,740](/filings/0001683168-25-008326.md) | [1,399](/filings/0001683168-25-008326.md) | [5,467](/filings/0001683168-26-006441.md) | [3,662](/filings/0001683168-26-006441.md) | [2,535](/filings/0001683168-26-006441.md) | [1,416](/filings/0001683168-25-008326.md) | [1,893](/filings/0001683168-26-006441.md) | [297](/filings/0001683168-26-006441.md) | [(431)](/filings/0001683168-26-006441.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(1,129) d](/filings/0001683168-24-008207.md) | [(2,314) d](/filings/0001683168-25-002130.md) | [(2,164)](/filings/0001683168-25-003561.md) | [(1,737) d](/filings/0001683168-25-006148.md) | [(1,067) d](/filings/0001683168-25-008326.md) | [(2,489) d](/filings/0001683168-26-002518.md) | [(1,801)](/filings/0001683168-26-004002.md) | [(1,279) d](/filings/0001683168-26-006441.md) | [(749) d](/filings/0001683168-25-008326.md) | [(1,060) d](/filings/0001683168-26-002518.md) | [(913)](/filings/0001683168-26-004002.md) | [(776) d](/filings/0001683168-26-006441.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [16.6](/filings/0001683168-23-008030.md) | [17.8](/filings/0001683168-24-003412.md) | [18.5](/filings/0001683168-24-005596.md) | [18.8](/filings/0001683168-24-008207.md) | [22.5](/filings/0001683168-25-003561.md) | [24.8](/filings/0001683168-25-006148.md) | [25.9](/filings/0001683168-25-008326.md) | [33.3](/filings/0001683168-26-004002.md) | [33.6](/filings/0001683168-26-006441.md) | [34.0](/filings/0001683168-25-008326.md) | [41.7](/filings/0001683168-26-004002.md) | [42.0](/filings/0001683168-26-006441.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 42,003,934 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001683168-26-006441.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.